HIV/AIDS

Web annexes

Consolidated ARV guidelines, June 2013


Chapter 7

Clinical guidance across the continuum of care: antiretroviral therapy

Guidelines section 7.1: When to start ART

Systematic reviews and GRADE tables

Section 7.1.1: When to start ART in adults and adolescents
Section 7.1.2: When to start ART in pregnant and breastfeeding women
Section 7.1.3: ARV drugs and duration of breastfeeding
Section 7.1.4: When to start ART in children

See also under Section 7.1.1: When to start ART: >350 cells/mm3 (individuals (adults, adolescents and children >5 years old) living with HIV)

Relevant modelling reports

Essential package of care for pregnant women

Section 7.1.3, Expands on Box 7.1 Special considerations for the care and management of pregnant women

Section 7.2: What ART regimen to start with (first-line ART)

Systematic reviews and GRADE tables

Section 7.2.1: First-line ART for adults
Section 7.2.2: First-line ART for pregnant and breastfeeding women and ARV drugs for their infants
Section 7.2.3: First-line ART for children younger than three years of age
Section 7.2.4: First-line ART for children three years and older (including adolescents)

ARV drug information for use in children

Section 7.2.3 and 7.2.4: First-line ART for children younger than three years of age & First-line ART for children three years and older (including adolescents)

1. ARV drug information tables for use in children

Guidelines section 7.3: Monitoring response to ART and the diagnosis of treatment failure

Systematic reviews and GRADE tables

Relevant modelling reports

Guidelines section 7.4: Monitoring and substitutions for ARV drug toxicities

Systematic reviews and GRADE tables

Section 7.4.3: Monitoring TDF toxicity

Relevant tables on ARV drug toxicities and ARV drug interactions

Section 7.5: What ART to switch to (second-line ART)

Systematic reviews and GRADE tables

Section 7.5.1 and 7.5.2
Share